Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Galluzzo

Showing results (31-40 of 111) with videos related to

Pageof 12
Sort By:
Journal of Drugs in Dermatology : JDD|August 4, 2012
Ustekinumab for treatment of plaque psoriasis in a patient with Down syndromeMarina Talamonti, Marco Galluzzo, Andrea Chiricozzi, et al.
Journal of Dermatological Case Reports|October 30, 2015
Long-term ustekinumab therapy of psoriasis in patients with coexisting rheumatoid arthritis and Sjögren syndrome. Report of two cases and review of literatureMaria Sole Chimenti, Marina Talamonti, Lucia Novelli, et al.
Expert Opinion on Biological Therapy|November 27, 2020
Impact of secukinumab on patient-reported outcomes in moderate to severe plaque psoriasis: a review of clinical studiesMarco Galluzzo, Marina Talamonti, Valeria Manfreda, et al.
Italian Journal of Dermatology and Venereology|November 4, 2024
Diagnosing psoriatic arthritis in the early phase: what factors should dermatologists consider for an appropriate referral of patients with psoriasis to rheumatologistsMarco Galluzzo, Rossana Scrivo, Annunziata Dattola, et al.
International Journal of Molecular Sciences|July 13, 2024
Blastic Plasmacytoid Dendritic Cell Neoplasm, from a Dermatological Point of ViewCosimo Di Raimondo, Flavia Lozzi, Pier Paolo Di Domenico, et al.
Journal of Clinical Medicine|May 14, 2022
Efficacy of Tildrakizumab for the Treatment of Difficult-to-Treat Areas: Scalp, Nail, Palmoplantar and Genital PsoriasisMarco Galluzzo, Marina Talamonti, Arnaldo Cioni, et al.
Dermatology Reports|June 3, 2025
Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumabAngela Fico, Edoardo Mortato, Claudia Paganini, et al.
Dermatology Reports|March 6, 2025
Rosacea-like eruptions associated with upadacitinib in atopic dermatitis: two case reports and management strategiesClaudia Paganini, Edoardo Mortato, Lorenzo Tofani, et al.
Journal of Clinical Medicine|July 13, 2024
Impact of Upadacitinib on Atopic Keratoconjunctivitis Exacerbated by Dupilumab Treatment in Atopic Dermatitis Patients: A Prospective Dermatological and Ophthalmological Clinical Evaluation in Common Clinical PracticeClaudia Paganini, Sara Spelta, Lorenzo Tofani, et al.
Journal of Clinical Medicine|July 15, 2020
Use of Guselkumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A 1 Year Real-Life StudyMarco Galluzzo, Lorenzo Tofani, Paolo Lombardo, et al.
Pageof 12

Showing results (31-40 of 111) with videos related to

Sort By:
Pageof 12
Journal of Drugs in Dermatology : JDD|August 4, 2012
Ustekinumab for treatment of plaque psoriasis in a patient with Down syndromeMarina Talamonti, Marco Galluzzo, Andrea Chiricozzi, et al.
Journal of Dermatological Case Reports|October 30, 2015
Long-term ustekinumab therapy of psoriasis in patients with coexisting rheumatoid arthritis and Sjögren syndrome. Report of two cases and review of literatureMaria Sole Chimenti, Marina Talamonti, Lucia Novelli, et al.
Expert Opinion on Biological Therapy|November 27, 2020
Impact of secukinumab on patient-reported outcomes in moderate to severe plaque psoriasis: a review of clinical studiesMarco Galluzzo, Marina Talamonti, Valeria Manfreda, et al.
Italian Journal of Dermatology and Venereology|November 4, 2024
Diagnosing psoriatic arthritis in the early phase: what factors should dermatologists consider for an appropriate referral of patients with psoriasis to rheumatologistsMarco Galluzzo, Rossana Scrivo, Annunziata Dattola, et al.
International Journal of Molecular Sciences|July 13, 2024
Blastic Plasmacytoid Dendritic Cell Neoplasm, from a Dermatological Point of ViewCosimo Di Raimondo, Flavia Lozzi, Pier Paolo Di Domenico, et al.
Journal of Clinical Medicine|May 14, 2022
Efficacy of Tildrakizumab for the Treatment of Difficult-to-Treat Areas: Scalp, Nail, Palmoplantar and Genital PsoriasisMarco Galluzzo, Marina Talamonti, Arnaldo Cioni, et al.
Dermatology Reports|June 3, 2025
Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumabAngela Fico, Edoardo Mortato, Claudia Paganini, et al.
Dermatology Reports|March 6, 2025
Rosacea-like eruptions associated with upadacitinib in atopic dermatitis: two case reports and management strategiesClaudia Paganini, Edoardo Mortato, Lorenzo Tofani, et al.
Journal of Clinical Medicine|July 13, 2024
Impact of Upadacitinib on Atopic Keratoconjunctivitis Exacerbated by Dupilumab Treatment in Atopic Dermatitis Patients: A Prospective Dermatological and Ophthalmological Clinical Evaluation in Common Clinical PracticeClaudia Paganini, Sara Spelta, Lorenzo Tofani, et al.
Journal of Clinical Medicine|July 15, 2020
Use of Guselkumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A 1 Year Real-Life StudyMarco Galluzzo, Lorenzo Tofani, Paolo Lombardo, et al.
Pageof 12